<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>47(3)</volume><submitter>Yoh T</submitter><pubmed_abstract>&lt;h4>Backgrounds&lt;/h4>In the era of multidisciplinary treatment strategy, resectability for hepatocellular carcinoma (HCC) should be defined. This study aimed to propose and validate a resectability classification of HCC.&lt;h4>Methods&lt;/h4>We proposed following the three groups; resectable-(R), borderline resectable-(BR), and unresectable (UR)-HCCs. Resectable two groups were sub-divided according to the value of indocyanine green clearance of remnant liver (ICG-Krem) and presence of macrovascular invasion (MVI); BR-HCC was defined as resectable HCCs with MVI and/or ICG-Krem≥0.03-&lt;0.05, and R-HCC was the remaining. Consecutive patients with HCC who underwent liver resection (LR) and non-surgical treatment(s) (i.e., UR-HCC) between 2011 and 2017 were retrospectively analyzed to validate the prop</pubmed_abstract><journal>World journal of surgery</journal><pagination>740-748</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9895025</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A Conceptual Classification of Resectability for Hepatocellular Carcinoma.</pubmed_title><pmcid>PMC9895025</pmcid><pubmed_authors>Seo S</pubmed_authors><pubmed_authors>Hatano E</pubmed_authors><pubmed_authors>Ito T</pubmed_authors><pubmed_authors>Fukumitsu K</pubmed_authors><pubmed_authors>Nishio T</pubmed_authors><pubmed_authors>Hata K</pubmed_authors><pubmed_authors>Koyama Y</pubmed_authors><pubmed_authors>Yoh T</pubmed_authors><pubmed_authors>Ishii T</pubmed_authors><pubmed_authors>Ogiso S</pubmed_authors><pubmed_authors>Uchida Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Conceptual Classification of Resectability for Hepatocellular Carcinoma.</name><description>&lt;h4>Backgrounds&lt;/h4>In the era of multidisciplinary treatment strategy, resectability for hepatocellular carcinoma (HCC) should be defined. This study aimed to propose and validate a resectability classification of HCC.&lt;h4>Methods&lt;/h4>We proposed following the three groups; resectable-(R), borderline resectable-(BR), and unresectable (UR)-HCCs. Resectable two groups were sub-divided according to the value of indocyanine green clearance of remnant liver (ICG-Krem) and presence of macrovascular invasion (MVI); BR-HCC was defined as resectable HCCs with MVI and/or ICG-Krem≥0.03-&lt;0.05, and R-HCC was the remaining. Consecutive patients with HCC who underwent liver resection (LR) and non-surgical treatment(s) (i.e., UR-HCC) between 2011 and 2017 were retrospectively analyzed to validate the prop</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Mar</publication><modification>2025-04-22T18:11:23.014Z</modification><creation>2025-04-06T02:23:18.511Z</creation></dates><accession>S-EPMC9895025</accession><cross_references><pubmed>36287266</pubmed><doi>10.1007/s00268-022-06803-7</doi></cross_references></HashMap>